Literature DB >> 2433527

Regulation of cyclic GMP synthesis and the interactions with calcium.

F Murad, S A Waldman, R R Fiscus, R M Rapoport.   

Abstract

The formation of cyclic GMP (cGMP) by guanylate cyclase, and the properties of the soluble and particulate isoenzymes, are reviewed. Regulation of guanylate cyclase and cGMP accumulation in intestinal mucosa and vascular smooth muscle with and without endothelium are summarized. The effects of E. coli heat-stable enterotoxin, nitrovasodilators, endothelium-dependent vasodilators, and atrial natriuretic factors in these systems are discussed. A potential role for free radicals, Ca, and unsaturated fatty acids in cGMP synthesis is reviewed. These tissue systems (intestinal mucosa and vascular smooth muscle with or without intact endothelium) are presented as model systems and as examples of the regulation of cGMP accumulation in a single cell type by peptides, drugs, and cell-cell interactions that are required to generate cGMP with a hormone or drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433527     DOI: 10.1097/00005344-198600088-00012

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

Review 1.  Causes and problems of nonresponse or poor response to drugs.

Authors:  P Salvà Lacombe; J A García Vicente; J Costa Pagès; P Lucio Morselli
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

2.  Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.

Authors:  Amanda M Pattison; Erik S Blomain; Dante J Merlino; Fang Wang; Mary Ann S Crissey; Crystal L Kraft; Jeff A Rappaport; Adam E Snook; John P Lynch; Scott A Waldman
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.

Authors:  A Mülsch; A Lückhoff; U Pohl; R Busse; E Bassenge
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.